| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/15/2023 |
4
| Coman David (CEO) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Paid exercise price by delivering 144,576 shares
@ $0.44, valued at
$63.6k
Exercised 495,122 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Forman Darcy (Chief Delivery Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Paid exercise price by delivering 84,380 shares
@ $0.44, valued at
$37.1k
Exercised 288,972 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Zaranek Mike (CFO) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Paid exercise price by delivering 74,813 shares
@ $0.44, valued at
$32.9k
Exercised 256,207 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Cotliar Jonathan (Chief Medical Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Paid exercise price by delivering 79,839 shares
@ $0.44, valued at
$35.1k
Exercised 230,882 restricted stock units
@ $0 |
|
| 08/15/2023 |
4
| Pellizzari Christine A (Chief Legal and HR Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Paid exercise price by delivering 86,577 shares
@ $0.44, valued at
$38.1k
Exercised 355,549 restricted stock units
@ $0 |
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 494,853 shares
@ $0.2526, valued at
$125k
|
|
| 05/15/2023 |
4
| Faulkner Robert C. (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 494,853 shares
@ $0.2526, valued at
$125k
|
|
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
4
| Bryenton Troy (Chief Technology Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| Tiwari Neil (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Exercised 40,983 restricted stock units
@ $0
Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| von Autenried Paul (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Exercised 46,040 restricted stock units
@ $0
Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| Hubbard John W (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Exercised 40,983 restricted stock units
@ $0
Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Exercised 40,983 restricted stock units
@ $0
Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| Shipton Michael (Chief Commercial Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 494,853 restricted stock units
@ $0 |
|
| 05/12/2023 |
3
| Bryenton Troy (Chief Technology Officer) has filed a Form 3 on Science 37 Holdings, Inc. |
| 05/11/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Cotliar Jonathan (Chief Medical Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 257,320 shares
@ $0
Disposed/sold 442,754 options
@ $10.05, valued at
$4.4M
Disposed/sold 200,549 options
@ $11.47, valued at
$2.3M
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Zaranek Mike (CFO) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 444,283 shares
@ $0
Disposed/sold 457,466 options
@ $9.06, valued at
$4.1M
Disposed/sold 185,897 options
@ $11.47, valued at
$2.1M
Disposed/sold 467,351 options
@ $10.05, valued at
$4.7M
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 04/19/2023 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 04/19/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
SC TO-I
| Form SC TO-I - Tender offer statement by Issuer: |
| 03/20/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/15/2023 |
4
| Shipton Michael (Chief Commercial Officer) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 522,793 restricted stock units
@ $0 |
|
|